Literature DB >> 10461427

Assessment of body composition using dual energy x-ray absorptiometry in patients with liver cirrhosis: comparison with anthropometry.

S H Jeong1, J A Lee, J A Kim, M W Lee, H B Chae, W J Choi, H S Shin, K H Lee, S J Youn, S S Koong, S M Park.   

Abstract

OBJECTIVES: The aim of this study was to evaluate changes of body composition in cirrhotic patients. Dual energy x-ray absorptiometry (DEXA) and anthropometry were used, and the values obtained were compared.
METHODS: Mid-arm fat and muscle areas were calculated by anthropometry in 66 cirrhotic patients and 94 healthy controls. In 37 of the cirrhotic patients and 39 of the controls, fat mass, lean soft tissue mass and bone mineral contents were measured with DEXA.
RESULTS: The number of cirrhotic patients with measured values below the fifth percentile of normal controls was 21 (31.8%) by mid-arm fat area, six (9.1%) by mid-arm muscle area, 15 (40.5%) by fat mass and 0 (0%) by lean soft tissue mass. The fat mass in cirrhotic patients was less than in controls, whereas lean soft tissue mass and bone mineral content were not different. Fat depletion was severe in Child-class C patients and with severe ascites. Mid-arm fat area and fat mass showed close correlation (r = 0.85, p < 0.01), but mid-arm muscle area and lean soft tissue mass showed poor correlation (r = 0.32, p < 0.05).
CONCLUSION: Cirrhotic patients showed lower fat component, with preserved lean soft tissue mass and bone mineral content. In clinical practice, the measurement of mid-arm fat area was useful for the assessment of fat mass.

Entities:  

Mesh:

Year:  1999        PMID: 10461427      PMCID: PMC4531921          DOI: 10.3904/kjim.1999.14.2.64

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  30 in total

1.  Protein-calorie malnutrition in liver cirrhosis.

Authors:  H U Lautz; O Selberg; J Körber; M Bürger; M J Müller
Journal:  Clin Investig       Date:  1992-06

2.  Relationships between upper-arm anthropometry and soft-tissue composition in postmenopausal women.

Authors:  I R Reid; M C Evans; R Ames
Journal:  Am J Clin Nutr       Date:  1992-09       Impact factor: 7.045

Review 3.  Nutritional therapy and liver disease.

Authors:  A J McCullough; K D Mullen; E J Smanik; M Tabbaa; K Szauter
Journal:  Gastroenterol Clin North Am       Date:  1989-09       Impact factor: 3.806

Review 4.  The assessment of body composition in patients with cirrhosis.

Authors:  M Y Morgan; A M Madden
Journal:  Eur J Nucl Med       Date:  1996-02

5.  Body composition of humans: comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure.

Authors:  S B Heymsfield; S Lichtman; R N Baumgartner; J Wang; Y Kamen; A Aliprantis; R N Pierson
Journal:  Am J Clin Nutr       Date:  1990-07       Impact factor: 7.045

Review 6.  Methods for the assessment of human body composition: traditional and new.

Authors:  H C Lukaski
Journal:  Am J Clin Nutr       Date:  1987-10       Impact factor: 7.045

7.  Measurements of total body and extracellular water in cirrhotic patients with and without ascites.

Authors:  A J McCullough; K D Mullen; S C Kalhan
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

8.  Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis.

Authors:  D Prijatmoko; B J Strauss; J R Lambert; W Sievert; D B Stroud; M L Wahlqvist; B Katz; J Colman; P Jones; M G Korman
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

Review 9.  Bioelectrical impedance analysis and dual energy x-ray absorptiometry to monitor nutritional status.

Authors:  S Stall; N S Ginsberg; R I Lynn; P M Zabetakis
Journal:  Perit Dial Int       Date:  1995       Impact factor: 1.756

10.  Short-term changes in energy metabolism after 1 month of a regular oral diet in severely malnourished cirrhotic patients.

Authors:  B Campillo; P N Bories; M Leluan; B Pornin; M Devanlay; P Fouet
Journal:  Metabolism       Date:  1995-06       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.